NDC 37000-441 – Pepto-Bismol Ultra Cherry
Bismuth Subsalicylate 525 mg/15mL · Suspension · Oral
Product NDC37000-441
Product details
- Brand name
- Pepto-Bismol Ultra Cherry
- Generic name
- Bismuth subsalicylate
- Labeler
- The Procter & Gamble Manufacturing Company
- Dosage form
- Suspension
- Route
- Oral
- Marketing category
- OTC MONOGRAPH DRUG · M008
- Marketed since
- March 1, 2018
- Listing expires
- December 31, 2026
Active ingredients
- Bismuth Subsalicylate 525 mg/15mL
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 37000-441-12 | 354 mL in 1 BOTTLE, PLASTIC (37000-441-12) | Mar 1, 2018 |
| 37000-441-16 | 473 mL in 1 BOTTLE, PLASTIC (37000-441-16) | Aug 3, 2025 |
| 37000-441-32 | 2 BOTTLE, PLASTIC in 1 CARTON (37000-441-32) / 473 mL in 1 BOTTLE, PLASTIC | Aug 3, 2025 |
Other Pepto Bismol products
- 37000-439 Bismuth Subsalicylate 525 mg/30mL · Suspension · The Procter & Gamble Manufacturing Company
- 37000-440 Bismuth Subsalicylate 525 mg/15mL · Suspension · The Procter & Gamble Manufacturing Company
- 69423-966 Bismuth Subsalicylate 525 mg/15mL · Suspension · The Procter & Gamble Manufacturing Company
- 37000-438 Bismuth Subsalicylate 525 mg/30mL · Suspension · The Procter & Gamble Manufacturing Company
- 76420-490 Bismuth Subsalicylate 262 mg/1 · Tablet · ASCLEMED USA INC.
- 66715-9723 Bismuth Subsalicylate 262 mg/1 · Tablet, Chewable · Lil' Drug Store Products, Inc.
- 67751-155 Bismuth Subsalicylate 262 mg/1 · Tablet, Chewable · Navajo Manufacturing Company Inc.
- 58933-476 Bismuth Subsalicylate 262 mg/1 · Tablet · Procter & Gamble Manufactura S de RL de CV
- 58933-013 Bismuth Subsalicylate 525 mg/21 · Tablet, Chewable · Procter & Gamble Manufactura S de RL de CV
- 58933-011 Bismuth Subsalicylate 262 mg/1 · Tablet, Chewable · Procter & Gamble Manufactura S de RL de CV
- 58933-002 Bismuth Subsalicylate 262 mg/1 · Tablet, Chewable · Procter & Gamble Manufactura S de RL de CV
- 58933-478 Bismuth Subsalicylate 525 mg/1 · Tablet · Procter & Gamble Manufactura, S. de R.L. de C.V.